Correlation Between Adaptimmune Therapeutics and Aytu BioScience
Can any of the company-specific risk be diversified away by investing in both Adaptimmune Therapeutics and Aytu BioScience at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Adaptimmune Therapeutics and Aytu BioScience into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Adaptimmune Therapeutics Plc and Aytu BioScience, you can compare the effects of market volatilities on Adaptimmune Therapeutics and Aytu BioScience and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Adaptimmune Therapeutics with a short position of Aytu BioScience. Check out your portfolio center. Please also check ongoing floating volatility patterns of Adaptimmune Therapeutics and Aytu BioScience.
Diversification Opportunities for Adaptimmune Therapeutics and Aytu BioScience
0.79 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Adaptimmune and Aytu is 0.79. Overlapping area represents the amount of risk that can be diversified away by holding Adaptimmune Therapeutics Plc and Aytu BioScience in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aytu BioScience and Adaptimmune Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Adaptimmune Therapeutics Plc are associated (or correlated) with Aytu BioScience. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aytu BioScience has no effect on the direction of Adaptimmune Therapeutics i.e., Adaptimmune Therapeutics and Aytu BioScience go up and down completely randomly.
Pair Corralation between Adaptimmune Therapeutics and Aytu BioScience
Given the investment horizon of 90 days Adaptimmune Therapeutics Plc is expected to generate 1.17 times more return on investment than Aytu BioScience. However, Adaptimmune Therapeutics is 1.17 times more volatile than Aytu BioScience. It trades about 0.0 of its potential returns per unit of risk. Aytu BioScience is currently generating about -0.02 per unit of risk. If you would invest 165.00 in Adaptimmune Therapeutics Plc on August 30, 2024 and sell it today you would lose (92.00) from holding Adaptimmune Therapeutics Plc or give up 55.76% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 99.8% |
| Values | Daily Returns |
Adaptimmune Therapeutics Plc vs. Aytu BioScience
Performance |
| Timeline |
| Adaptimmune Therapeutics |
| Aytu BioScience |
Adaptimmune Therapeutics and Aytu BioScience Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Adaptimmune Therapeutics and Aytu BioScience
The main advantage of trading using opposite Adaptimmune Therapeutics and Aytu BioScience positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Adaptimmune Therapeutics position performs unexpectedly, Aytu BioScience can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aytu BioScience will offset losses from the drop in Aytu BioScience's long position.The idea behind Adaptimmune Therapeutics Plc and Aytu BioScience pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Aytu BioScience vs. Aquestive Therapeutics | Aytu BioScience vs. Evoke Pharma | Aytu BioScience vs. Shionogi Co Ltd | Aytu BioScience vs. Sunshine Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |